Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

: GroupAssignment: Quadpill vs. Candesartan - JSON Representation

Raw json | Download

{
  "resourceType" : "EvidenceVariable",
  "id" : "375183",
  "meta" : {
    "versionId" : "4",
    "lastUpdated" : "2025-06-10T18:29:54.548Z",
    "profile" : [
      🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/group-assignment"
    ]
  },
  "text" : {
    "status" : "empty",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"
  },
  "url" : "https://fevir.net/resources/EvidenceVariable/375183",
  "identifier" : [
    {
      "type" : {
        "coding" : [
          {
            "system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code" : "ACSN",
            "display" : "Accession ID"
          }
        ],
        "text" : "FEvIR Object Identifier"
      },
      "system" : "urn:ietf:rfc:3986",
      "value" : "https://fevir.net/FOI/375183",
      "assigner" : {
        "display" : "Computable Publishing LLC"
      }
    }
  ],
  "name" : "GroupAssignment_Quadpill_vs_Candesartan",
  "title" : "GroupAssignment: Quadpill vs. Candesartan",
  "citeAs" : "GroupAssignment: Quadpill vs. Candesartan [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 375183. Revised 2025-06-10. Available at: https://fevir.net/resources/EvidenceVariable/375183. Computable resource at: https://fevir.net/resources/EvidenceVariable/375183#json.",
  "status" : "active",
  "author" : [
    {
      "name" : "Brian S. Alper, MD, MSPH"
    }
  ],
  "publisher" : "Computable Publishing LLC",
  "contact" : [
    {
      "telecom" : [
        {
          "system" : "email",
          "value" : "support@computablepublishing.com"
        }
      ]
    }
  ],
  "description" : "Example of GroupAssignment Profile",
  "useContext" : [
    {
      "code" : {
        "system" : "https://fevir.net/resources/CodeSystem/179423",
        "code" : "evidence-communication",
        "display" : "Evidence Communication"
      },
      "valueCodeableConcept" : {
        "coding" : [
          {
            "system" : "https://fevir.net/resources/CodeSystem/179423",
            "code" : "GroupAssignment",
            "display" : "GroupAssignment"
          }
        ]
      }
    }
  ],
  "copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/",
  "definition" : {
    "concept" : {
      "coding" : [
        {
          "system" : "https://fevir.net/resources/CodeSystem/179423",
          "code" : "defined-in-handling-and-category",
          "display" : "Defined in handling and category elements"
        }
      ]
    }
  },
  "handling" : "dichotomous",
  "category" : [
    {
      "name" : "Quadpill once daily",
      "valueReference" : {
        🔗 "reference" : "Group/375175",
        "type" : "Group",
        "display" : "QUARTET USA Trial Quadpill group"
      }
    },
    {
      "name" : "Candesartan 8 mg once daily",
      "valueReference" : {
        🔗 "reference" : "Group/375182",
        "type" : "Group",
        "display" : "QUARTET USA Trial Control Group"
      }
    }
  ]
}